While less prevalent among all types of bladder cancers, invasive bladder tumors affect the muscle wall. Unlike superficial bladder cancer, these have a propensity to metastasize and spread to other areas of the body, and are more likely to be fatal. This book presents state-of-the-art diagnoses and treatments available for bladder cancer that has metastasised into the body. A thorough review of current practice is presented in a full color volume with more than 40 tables and 50 illustrations. The book offers a comprehensive review of the subject, covering epidemiology, screening, diagnostic factors, surgery, chemotherapy and post-operative monitoring. The authors and contributors comprise an international community of experts with experience in many medical disciplines. The book offers a concise, up-to-date overview, building a needed bridge from basic research to clinical practice. Indeed, most chapters are jointly written by a basic researcher and a clinician.
Edited by:
PierFrancesco Bassi, Francesco Pagano Imprint: Springer London Ltd Country of Publication: United Kingdom Edition: Softcover reprint of the original 1st ed. 2007 Dimensions:
Height: 235mm,
Width: 155mm,
Spine: 17mm
Weight: 646g ISBN:9781447171287 ISBN 10: 1447171284 Pages: 303 Publication Date:23 August 2016 Audience:
Professional and scholarly
,
Undergraduate
Format:Paperback Publisher's Status: Active
Epidemiology and prevention of bladder cancer.- Early diagnosis and screening.- Non-invasive diagnosis.- Molecular pathology of tumour progression and metastasis.- Staging: Past, present and future.- Magnetic resonance imaging.- Prognostic factors.- Surgical management.- Transurethral resection in patients with muscle-infiltrating bladder cancer.- Nodal involvement.- Pre-operative and definitive radiation therapy.- Neo-adjuvant and adjuvant chemotherapy — true and false.- Oncological rationale for function-sparing surgery.- Combination therapy and function-sparing surgery for muscle-invasive bladder cancer.- Chemotherapy of metastatic transitional cell cancer.- Invasive transitional cell cancer in the elderly.- Quality of life.- Urethra involvement and bladder cancer.- Lower urinary tract reconstruction.- Salvage cystectomy.